spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Dry Eye 

 HSMN NewsFeed - 2 Mar 2022
RegeneRx Provides Regulatory Update Regarding RGN-259
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA
 HSMN NewsFeed - 18 Oct 2021
Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 23 Jul 2021
Johnson & Johnson Vision Introduces VERITAS Vision System With Features To Address Key Unmet Needs In Cataract Surgery
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 21 Apr 2021
Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS(TM) Vision System
Devices Ophthalmology FDA Regulatory
 HSMN NewsFeed - 13 Apr 2021
Bausch & Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2021
Johnson & Johnson Vision Receives Approval of World's First and Only Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE(R) Theravision(TM) with Ketotifen
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 21 Sep 2020
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 17 Aug 2020
Bausch & Lomb Launches Innovative Bausch & Lomb INFUSE(TM) Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 10 Aug 2020
Sight Sciences Announces First Patients Enrolled in ORION: A Prospective, Multicenter Clinical Trial of the OMNI Surgical System in Pseudophakic, Mild-to-Moderate Glaucoma Patients
Devices Ophthalmology
 HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 May 2020
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 19 Feb 2020
Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Pembrolizumab in First-Line Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Dec 2019
Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 9 Dec 2019
Sight Sciences Appoints Erica Rogers to its Board of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Oct 2019
International MIGS Study Confirms Long-Term Safety and Efficacy of the OMNI(R) Surgical System Predicate Device (VISCO360(R))
Devices Ophthalmology
 HSMN NewsFeed - 30 Sep 2019
Johnson & Johnson Vision Care, Inc. Introduces ACUVUE(TM) RevitaLens Multi-Purpose Disinfecting Solution, the Brand's First Contact Lens Solution
Biopharmaceuticals Devices Ophthalmology Product Launch
 HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Mar 2019
Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 21 Mar 2019
RegeneRx Announces New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2019
Clinical Study Demonstrates Long Term IOP Reduction with the OMNI(R) Surgical System Predicate Device (TRAB(R)360) in Micro-Invasive Glaucoma Surgery
Devices Ophthalmology
 HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2019
Clinical Trial Reports That Re-Treatment With A Single TearCare(R) Treatment Continues To Provide Relief For Patients With Dry Eye Disease
Devices Ophthalmology
 HSMN NewsFeed - 29 Jan 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2019
Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF Alpha Antibody Fragment
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 4 Jan 2019
Oculis Raises CHF15.5 Million in an Extension of its Series B Financing Round - Total Raised CHF35.5 Million
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 6 Sep 2018
Johnson & Johnson Vision Launches Next Generation of Personalized LASIK Treatment, iDESIGN Refractive Studio Now Available
Devices Ophthalmology FDA Product Launch
 HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 10 May 2018
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 25 Apr 2018
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 24 Apr 2018
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 20 Mar 2018
Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 Mar 2018
Sight Sciences Names Jesse Selnick Chief Financial Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 8 Jan 2018
I-PEN(R), I-DROP(R) and I-PLUG(R) now available in Spain and Portugal through Partnership with IMEX
Devices Ophthalmology Distribution
 HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces TearScience LipiScan(R) and LipiFlow(R) Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces Series of Product Milestones and Launches Across Portfolio at American Academy of Ophthalmology 2017 Meeting
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 19 Oct 2017
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 9 Oct 2017
Sight Sciences Secures $10MM in Oversubscribed Series C Financing
Devices Ophthalmology Venture Capital Personnel
 HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 8 May 2017
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 May 2017
TearScience Introduces LipiFlow(R) Activator II
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 2 May 2017
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
Biopharmaceuticals Devices Ophthalmology Distribution
 HSMN NewsFeed - 1 May 2017
Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 22 Mar 2017
Allergan Announces Availability of RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 18 Nov 2016
AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2016
Allergan Introduces RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help Patients Produce More of Their Own Tears
Biopharmaceuticals Ophthalmology FDA Product Launch
 HSMN NewsFeed - 13 Oct 2016
Ocular Therapeutix(TM) and Regeneron Enter Into Strategic Collaboration to Develop Sustained Release Formulation of Aflibercept for the Treatment of Wet AMD and Other Serious Retinal Diseases
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 6 Oct 2016
Novaliq Strengthens Executive Management Team by Appointing Christian Roesky, PhD, as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Sep 2016
AcuFocus Raises $66 Million in New Financing Round Led by KKR
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 12 Jul 2016
FDA Approves Shire’s Xiidra(TM) (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 28 Jun 2016
iSTAR Medical Strengthens Board With Two Senior Appointments
Devices Ophthalmology Personnel
 HSMN NewsFeed - 19 May 2016
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Devices Ophthalmology
 HSMN NewsFeed - 5 May 2016
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 5 May 2016
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 4 May 2016
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
Devices Monitoring Ophthalmology Personnel
 HSMN NewsFeed - 10 Mar 2016
Allergan Receives Complete Response Letter from FDA for Prior Approval Supplement for RESTASIS(R) (Cyclosporine Ophthalmic Emulsion) 0.05% Multi-Dose Preservative-Free Bottle
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 29 Jan 2016
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Jan 2016
Boehringer Ingelheim's Gilotrif(R) Demonstrated Superiority to Iressa(R) (Gefitinib) in Reducing the Risk of Disease Progression and Treatment Failure in First-Line Treatment of Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2016
BioLight Reports Positive Second Clinical Study Results for its TeaRx(TM) Multi-Assay Test for Dry Eye Syndrome
Diagnostics Ophthalmology
 HSMN NewsFeed - 4 Nov 2015
Allergan Enters Into Licensing Agreement with Mimetogen Pharmaceuticals to Develop and Commercialize Tavilermide (MIM-D3) Topical Dry Eye Treatment
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 6 Jul 2015
Allergan to Acquire Oculeve Dry Eye Disease Development Programs
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 20 Jan 2015
NovaBay Expands Sales Force for Avenova
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 15 Jan 2015
OCuSOFT(R) Introduces HypoChlor(TM) Spray and Gel (Hypochlorous Acid 0.02%) As Adjunct Therapy to its Lid Scrub(R) Family of Eyelid Cleansers
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 25 Nov 2014
Eleven Biotherapeutics Announces Additional Financing of $20 Million
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 29 Sep 2014
Allergan Announces FDA Approves Revised Indication for OZURDEX(R) (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Drug Delivery FDA
 HSMN NewsFeed - 25 Aug 2014
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
Biopharmaceuticals Ophthalmology Distribution
 HSMN NewsFeed - 23 Jul 2014
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 19 May 2014
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 23 Apr 2014
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 16 Apr 2014
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 31 Dec 2013
OphthaliX to Conduct a Retrospective Analysis of the Phase III Dry Eye Syndrome Study Data Based on the A3 Adenosine Receptor Biomarker
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Dec 2013
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 24 Oct 2013
Rigel Provides Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2013
FDA Approves JUVÉDERM VOLUMA(TM) XC
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 30 Jul 2013
Edimer Secures $18M Series B Financing Led by New Enterprise Associates
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2012
Sucampo Announces FDA Approval of an sNDA for RESCULA(R) (unoprostone isopropyl)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 5 Sep 2012
InSite Vision Introduces DuraSite 2(R) Ophthalmic Drug Delivery System
Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 2 May 2012
TearScience’s LipiFlow(R) Treatments a Highlight at American Society of Cataract & Refractive Surgery (ASCRS) Congress
Devices Ophthalmology
 HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Biopharmaceuticals Neurology Regenerative Medicine
 HSMN NewsFeed - 1 Feb 2012
TearScience Achieves FDA Clearance for Second Generation LipiFlow(R) Thermal Pulsation System
Devices Ophthalmology FDA
 HSMN NewsFeed - 21 Dec 2011
Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 29 Nov 2011
Visian(R) Toric ICL(TM) Approved to Market in Japan
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 28 Nov 2011
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
Devices Ophthalmology Drug Delivery Litigation
 HSMN NewsFeed - 13 Oct 2011
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Sep 2011
Pfizer Announces Detailed Pivotal Data for Investigational Compound Tofacitinib in Rheumatoid Arthritis to be Presented at American College of Rheumatology 2011 Annual Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2011
TearScience(R) Appoints Diethart Reichardt as Senior Vice President of European Region
Devices Personnel
 HSMN NewsFeed - 8 Aug 2011
Acucela Appoints Michelle Carpenter, J.D., RAC, as Senior Vice President, Regulatory Affairs & Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2011
SARcode Bioscience Completes $44 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jul 2011
TearScience Gains U.S. FDA Clearance for the LipiFlow(R) Thermal Pulsation System for Treating Evaporative Dry Eye
Devices Ophthalmology FDA
 HSMN NewsFeed - 28 Apr 2011
Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 5 Apr 2011
Merck to Acquire Inspire Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Mar 2011
TearScience Appoints Jeff O’Hara as Vice President of Sales
Devices Ophthalmology Personnel
 HSMN NewsFeed - 17 Feb 2011
Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 2 Feb 2011
Ocular Therapeutix, Inc. Completes Series D Financing to Support Phase II Sustained Drug Delivery Clinical Trials
Devices Drug Delivery Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Jan 2011
EyeGate Pharma Secures Additional $5.9M Series D Venture Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 3 Jan 2011
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 21 Dec 2010
TearScience Wins SEBIO Award for Securing $44.5 Million in Venture Funding in 2010
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 13 Dec 2010
Inspire Announces Launch of DIQUASTM by Santen in Japan
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Nov 2010
ISTA Pharmaceuticals Granted Three-Year Market Exclusivity for BROMDAY
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Oct 2010
Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
Devices Ophthalmology Drug Delivery
 HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2010
Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Apr 2010
EyeGate Pharma Establishes Research Collaboration With GlaxoSmithKline to Deliver Medicines Using the EyeGate(R) II Delivery System
Devices Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 13 Apr 2010
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Mar 2010
Inspire Elects George Abercrombie to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2010
Inspire Names Adrian Adams as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2010
EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 4 Nov 2009
Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 21 Oct 2009
Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
Diagnostics Ophthalmology Wound Care
 HSMN NewsFeed - 21 Oct 2009
MacuSight(R) Receives Fast Track Designation From FDA for Perceiva(TM) in Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 9 Oct 2009
Lycera Appoints Key Executives to Drug Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2009
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 16 Sep 2009
Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 23 Jul 2009
Allergan Receives FDA Approval for ACUVAIL Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Jun 2009
Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 19 May 2009
TearLab Corporation Announces FDA 510(k) Clearance of the TearLab(tm) Osmolarity System
Diagnostics Ophthalomology FDA
 HSMN NewsFeed - 5 May 2009
Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2009
Aton Pharma Acquires U.S. TIMOPTIC(R)
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 16 Feb 2009
Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 26 Jan 2009
Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 15 Jan 2009
ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Jan 2009
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
Devices Ophthalmology Acquisitions
 HSMN NewsFeed - 9 Jan 2009
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 6 Nov 2008
MacuSight Appoints Gerald Wroblewski Vice President of Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 26 Sep 2008
ISTA Pharmaceuticals Receives $65 Million Funding Commitment
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Jun 2008
Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation and Pain
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 16 Jun 2008
EyeGate Pharma Appoints Amy Cohen as Vice President, Clinical Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Jun 2008
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
Biopharmaceuticals Ophthalmology Drug Delivery Personnel
 HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Apr 2008
Novagali Pharma Announces the Launch of Cationorm(R)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 Apr 2008
Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon from Nestlé with right to take over majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 1 Apr 2008
Advanced Medical Optics Introduces TECNIS(R) 1-Piece Intraocular Lens in U.S.
Devices Ophthalmology
 HSMN NewsFeed - 12 Mar 2008
EyeGate Pharma Secures $15M in Series C Venture Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 14 Feb 2008
Zecotek Announces New Surgical Laser
Devices Surgery
 HSMN NewsFeed - 30 Jan 2008
Lux Granted Fast Track Designation for LX201 for Corneal Transplant Rejection
Biopharmaceuticals Ophthalmology Drug Delivery FDA
 HSMN NewsFeed - 18 Jan 2008
Novagali Pharma Announces FDA Clearance of IND for US Clinical Trial of Nova63035 in Patients With Diabetic Macular Edema
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 14 Jan 2008
Inspire Announces Its Termination of Bilastine Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Nov 2007
ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 6 Nov 2007
Can-Fite: CF101 May Be Effective for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 2 Nov 2007
RegeneRx Receives First Ophthalmic Wound-Healing Patent in China
Biopharmaceuticals Wound Care Ophthalmology
 HSMN NewsFeed - 25 Oct 2007
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Oct 2007
QLT Completes Acquisition of ForSight Newco II, Inc.
Biopharmaceuticals Ophthalmology Drug Delivery
 HSMN NewsFeed - 9 Oct 2007
QLT acquires leading edge ocular drug delivery system from ForSight Labs
Biopharmaceuticals Ophthalmology Drug Delivery
 HSMN NewsFeed - 26 Sep 2007
ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Sep 2007
Bausch & Lomb Launches the Stellaris(TM) Vision Enhancement System in Europe at ESCRS 2007
Devices Ophthalmology
 HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 13 Aug 2007
InSite Vision Announces U.S. Launch of AzaSite(TM) for Ocular Infections
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 Aug 2007
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 1 Aug 2007
Bausch & Lomb Acquires Soothe(R) Emollient (Lubricant) Eye Drops from Alimera Sciences; Expands Product Line
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 31 Jul 2007
EMEA Committee for Orphan Medicinal Products Recommends Orphan Medicinal Product Designation for Lux Biosciences' LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Biopharmaceuticals Urology
 HSMN NewsFeed - 11 Jul 2007
Dr. William E. Cochran Joins arGentis Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2007
Karin Ludwig, M.D. Joins Alacrity Biosciences as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 5 Jul 2007
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2007
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Jun 2007
Novagali Pharma Strengthens its Executive Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2007
Inspire and FAES Farma Amend Bilastine Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Jun 2007
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2007
Novagali Pharma Receives US FDA Orphan Drug Designation for Vekacia(R) for the Treatment of Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 May 2007
ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Apr 2007
Inspire Announces FDA Approval Of AzaSite(TM)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Apr 2007
Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Apr 2007
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 4 Apr 2007
Novagali Pharma Announces Positive Vekacia(R) Clinical Results From Pivotal Phase III Trial in Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 Mar 2007
GSK Announces Nationwide Availability of Once-A-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Feb 2007
Inspire Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2007
Inspire Licenses AzaSite(TM) For Ocular Infections
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 8 Feb 2007
ISTA Pharmaceuticals Announces Positive Preliminary Xibrom(TM) Once-daily Formulation Clinical Results From U.S. Phase III Trials
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Jan 2007
Inspire Provides Cystic Fibrosis Clinical Program Update
Biopharmaceuticals
 HSMN NewsFeed - 15 Jan 2007
Lux Biosciences Receives Orphan Drug Designation from the FDA for Two Ophthalmic Products
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 4 Jan 2007
Inspire Announces Dry Eye Program Update
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 21 Dec 2006
ISTA Pharmaceuticals Submits Investigational New Drug Application for Eye Drop Formulation of Bepotastine for the Treatment of Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 28 Nov 2006
Lux Biosciences Receives FDA Clearance for LX211 IND
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 11 Nov 2006
Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting
Devices Ophthalmology
 HSMN NewsFeed - 1 Nov 2006
Inspire and FAES Farma Announce Licensing Agreement for New Oral Antihistamine to Target Allergy Market in United States and Canada
Biopharmaceuticals LIcensing
 HSMN NewsFeed - 20 Oct 2006
FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Sep 2006
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 7 Aug 2006
Inspire Announces Vice President Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2006
Inspire Initiates Phase 3 Clinical Trial of Denufosol Tetrasodium in Cystic Fibrosis Patients
Biopharmaceuticals
 HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2006
ISTA Pharmaceuticals Files New Drug Application with U.S. Food and Drug Administration for T-Pred(TM), a Tobramycin and Prednisolone Acetate Combination Product
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 30 May 2006
ISTA Pharmaceuticals Is Initiating Phase III Clinical Trials of a New Once-Daily Formulation of Xibrom(TM) for the Treatment of Ocular Pain and Inflammation Following Cataract Surgery
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 May 2006
New Data Show COREG CR (TM) Reduced Blood Pressure in Patients With Essential Hypertension
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 May 2006
Barr Receives Approval for Isotretinoin Capsules USP, 30 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 May 2006
ISTA Pharmaceuticals(R) Announces Study Indicating Twice-Daily Dosing of Xibrom(TM) as Equivalent to Four Times a Day of Other Treatments
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 May 2006
Othera Pharmaceuticals Elects Katherine Crothall and Bruce Peacock to Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2006
ISTA Pharmaceuticals Reports Simple Model Predicts Treatment Success With Vitrase(R) in Vitreous Hemorrhage Associated With Diabetes
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 10 Apr 2006
Somaxon Pharmaceuticals Announces Positive Phase 3 Results with SILENOR(TM) for the Treatment of Adults with Chronic Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 28 Mar 2006
Inspire Announces Outcome of FDA Meeting on Dry Eye Program
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 22 Mar 2006
Othera Pharmaceuticals Appoints Al Reaves as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2006
New Drug Application for COREG CR(TM) Accepted for Review by U.S. Food and Drug Administration
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Feb 2006
ISTA Pharmaceuticals Announces Positive Phase III Results for Tobramycin and Prednisolone Acetate Combination Product
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Jan 2006
ISTA Pharmaceuticals Receives FDA Approval for Expanded Indication of Xibrom(TM) to Treat Pain Following Cataract Surgery
Biopharmaceuticals Ophthalmology Surgery FDA
 HSMN NewsFeed - 12 Jan 2006
ISTA Pharmaceuticals Announces Acceptance of ISTA's European Marketing Application for Ovine Hyaluronidase for the Treatment of Vitreous Hemorrhage
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 11 Jan 2006
Novagali Pharma Successfully Completes Phase II Clinical Study With its Ophthalmic Formulation of Cyclosporine A
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 Jan 2006
Nascent Reports Positive Results for Phase II Dry Eye Treatment
Biopharmaceuticals Ophthalmology
Return to NewsFeed  

 Additional items found! 41

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 41 additional stories matching:
Dry Eye
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.